(Press-News.org) BOSTON, MA—Researchers from Brigham and Women's Hospital (BWH) have made a groundbreaking discovery that will shape the future of melanoma therapy. The team, led by Thomas S. Kupper, MD, chair of the BWH Department of Dermatology, and Rahul Purwar, PhD, found that high expression of a cell-signaling molecule, known as interleukin-9, in immune cells inhibits melanoma growth.
Their findings will be published online in the July 8, 2012 issue of Nature Medicine.
After observing mice without genes responsible for development of an immune cell called T helper cell 17 (TH17), researchers found that these mice had significant resistance to melanoma tumor growth, suggesting that blockade of the TH17 cell pathway favored tumor inhibition. The researchers also noticed that the mice expressed high amounts of interleukin-9.
"These were unexpected results, which led us to examine a possible contribution of interleukin-9 to cancer growth suppression." said Purwar.
The researchers next treated melanoma-bearing mice with T helper cell 9 (TH9), an immune cell that produces interleukin-9. They saw that these mice also had a profound resistance to melanoma growth. This is the first reported finding showing an anti-tumor effect of TH9 cells.
Moreover, the researchers were able to detect TH9 cells in both normal human blood and skin, specifically in skin-resident memory T cells and memory T cells in peripheral blood mononuclear cells. In contrast, TH9 cells were either absent or present at very low levels in human melanoma. This new finding paves the way for future studies that will assess the role of interleukin-9 and TH9 cells in human cancer therapy.
"Immunotherapy of cancer is coming of age, and there have been exciting recent results in patients with melanoma treated with drugs that stimulate the immune system," said Kupper. "We hope that our results will also translate to the treatment of melanoma patients, but much work still needs to be done."
According to the researchers, other cell-signaling molecules have been used in treating melanoma; however, this study is the first to investigate the role of interleukin-9 in melanoma tumor immunity.
Melanoma is the most dangerous form of skin cancer. The National Cancer Institute estimates that in 2012, there will be more than 76,000 new cases of melanoma in the United States and 9,180 deaths. Melanoma is curable if recognized and treated early.
###
This research was supported by the United States National Institutes of Health (R01 AI-41707, R01 AI-097128, P50 CA-093683, R01-AR-056720, R03-MH-095529 and Z01-ES-101586) and The Skin Cancer Foundation.
Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH has more than 3.5 million annual patient visits, is the largest birthing center in New England and employs nearly 15,000 people. The Brigham's medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care, quality improvement and patient safety initiatives, and its dedication to research, innovation, community engagement and educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving nearly 1,000 physician-investigators and renowned biomedical scientists and faculty supported by nearly $625 million in funding. BWH continually pushes the boundaries of medicine, including building on its legacy in organ transplantation by performing the first face transplants in the U.S. in 2011. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies, OurGenes and the Women's Health Initiative. For more information and resources, please visit BWH's online newsroom.
Researchers discover molecule in immune system that could help treat dangerous skin cancer
2012-07-09
ELSE PRESS RELEASES FROM THIS DATE:
Overweight? There's a vaccine for that
2012-07-09
New vaccines promote weight loss. A new study, published in BioMed Central's open access journal, Journal of Animal Science and Biotechnology, assesses the effectiveness of two somatostatin vaccinations, JH17 and JH18, in reducing weight gain and increasing weight loss in mice.
Obesity and obesity-related disease is a growing health issue worldwide. Somatostatin, a peptide hormone, inhibits the action of growth hormone (GH) and insulin-like growth factor (IGF-1), both of which increase metabolism and result in weight loss. Vaccination with modified somatostatin causes ...
Girls' mathematics performance more likely to suffer than boys' as a result of mathematics anxiety
2012-07-09
If a train is travelling a distance of 55 miles at 150mph, how long will it take to reach its destination? If the thought of having to answer this question makes you apprehensive, then you may have mathematics anxiety. A new study published today in BioMed Central's open access journal Behavioral and Brain Functions reports that a number of school-age children suffer from mathematics anxiety and, although both genders' performance is likely to be affected as a result, girls' maths performance is more likely to suffer than boys'.
Mathematics anxiety is a state of discomfort ...
Exome sequencing of health condition extremes can reveal susceptibility genes
2012-07-09
Comparing the DNA from patients at the best and worst extremes of a health condition can reveal genes for resistance and susceptibly. This approach discovered rare variations in the DCTN4 gene among cystic fibrosis patients most prone to early, chronic airway infections.
The DCTN4 gene codes for dynactin 4. This protein is a component of a molecular motor that moves trouble-making microbes along a cellular conveyer belt into miniscule chemical vats, called lysosomes, for annihilation.
This study, led by the University of Washington, is part of the National Heart ...
Unprecedented subatomic details of exotic ferroelectric nanomaterials
2012-07-09
UPTON, NY - As scientists learn to manipulate little-understood nanoscale materials, they are laying the foundation for a future of more compact, efficient, and innovative devices. In research to be published online July 8 in the journal Nature Materials, scientists at the U.S. Department of Energy's Brookhaven National Laboratory, Lawrence Berkeley National Laboratory, and other collaborating institutions describe one such advance - a technique revealing unprecedented details about the atomic structure and behavior of exotic ferroelectric materials, which are uniquely ...
Transcription factor Lyl-1 critical in producing early T-cell progenitors
2012-07-09
HOUSTON - (July 8, 2012) – A transcription factor called Lyl-1 is necessary for production of the earliest cells that can become T-cells, critical cells born in the thymus that coordinate the immune response to cancer or infections, said a consortium of researchers led by those from Baylor College of Medicine (www.bcm.edu) in a report in the journal Nature Immunology.
These earliest progenitors (called early T lineage progenitor cells) are the first cells that can be identified as being on the road to becoming T-cells, said Dr. Margaret Goodell (http://www.bcm.edu/star/index.cfm?pmid=2947), ...
Study finds 'mad cow disease' in cattle can spread widely in ANS before detectable in CNS
2012-07-09
Philadelphia, PA, July 9, 2012 – Bovine spongiform encephalopathy (BSE, or "mad cow disease") is a fatal disease in cattle that causes portions of the brain to turn sponge-like. This transmissible disease is caused by the propagation of a misfolded form of protein known as a prion, rather than by a bacterium or virus. The average time from infection to signs of illness is about 60 months. Little is known about the pathogenesis of BSE in the early incubation period. Previous research has reported that the autonomic nervous system (ANS) becomes affected by the disease ...
HPV vaccine reduces infection, even in unvaccinated
2012-07-09
The HPV vaccine not only has resulted in a decrease in human papillomavirus infection in immunized teens but also in teens who were not immunized.
The study is believed to be the first to show a substantial decrease in HPV infection in a community setting as well as herd protection – a decrease in infection rates among unimmunized individuals that occurs when a critical mass of people in a community is immunized against a contagious disease.
The Cincinnati Children's Hospital Medical Center study will be published online July 9 in the eFirst pages of Pediatrics.
"Infection ...
Researchers create 'MRI' of the sun's interior motions
2012-07-09
A team of scientists has created an "MRI" of the Sun's interior plasma motions, shedding light on how it transfers heat from its deep interior to its surface. The result, which appears in the journal the Proceedings of the National Academy of Sciences, upends our understanding of how heat is transported outwards by the Sun and challenges existing explanations of the formation of sunspots and magnetic field generation.
The work was conducted by researchers from NYU's Courant Institute of Mathematical Sciences and its Department of Physics, Princeton University, the Max ...
New gene transfer strategy shows promise for limb girdle and other muscular dystrophies
2012-07-09
The challenge of treating patients with genetic disorders in which a single mutated gene is simply too large to be replaced using traditional gene therapy techniques may soon be a thing of the past. A Nationwide Children's Hospital study describes a new gene therapy approach capable of delivering full-length versions of large genes and improving skeletal muscle function. The strategy may hold new hope for treating dysferlinopathies and other muscular dystrophies.
A group of untreatable muscle disorders known as dysferlinopathies are caused by mutations in the dysferlin ...
"Planning Your Restaurant's Successful Grand Opening is Critical," says Restaurant Expert Howard Cannon
2012-07-09
On the day when your dream comes true, make sure that the customer believes that eating in your restaurant is as much of a dream come true as you do. The opening of a restaurant involves more than picking a day and opening the doors. A restaurant opening is an event that you use to create a first impression.
Marketing starts early, way before the Grand Opening. Cannon says, "Write down your marketing goals. Formulate a plan. Build action steps. Then execute the plan. It's best to get professional help to create a marketing plan and build the appropriate action steps. ...